SBFM FY 2022 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$4M+1802.6% YoY

Gross Profit

$2M39.0% margin

Operating Income

-$27M-621.3% margin

Net Income

-$27M-615.4% margin

EPS (Diluted)

$-3523.64

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$6M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$30M

Total Liabilities

$8M

Stockholders' Equity

$22M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$228,426	+1802.6%
Gross Profit	$2M	$110,596	+1434.4%
Operating Income	-$27M	-$2M	-1006.6%
Net Income	-$27M	-$12M	-115.1%